1Silber S,Albertsson P,Aviles FF,et al.Guidelines for Percutaneous Coronary Interventions.The task force for percu taneou s coronary in terventions of the Eu ropean society of cardiology[J].Eur Heart J,2008,26(8):804.
6Brosh D,Assali A R,Mager A,et al.Effect of no-flow during primary percutaneous coronary intervention for acute myocardial infarction on six-month mortality[J].Am J Cardiol,2007,99(4):442.
7Movhed M R,Butman S M.The pathogenesis and treatment of no-reflow occurring during percutaneous coronary intervention[J].Cardiovasc Revasc Med,2008,9(1):56.
8Morishima I, Sone T, Okumura K, et al. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients trea- ted with percutaneous transluminal coronary angiop lasty for first acute myocardial infarction [ J ]. J Am Coil Cardiol, 2000,36 ( 4 ) : 1202- 1209.
9Yang TY, Chang ST, Chung CM,et al. Restoration of normal coronary flow with tirofiban by intracoronary administration for no reflow phe- nomenon after steut deployment [ J ]. Int Heart J,2005,46 ( 1 ) : 139- 145.
10Hochman JS, Lamas GA, Buller CE, et al. Coronary intervention for persistent occlusion after myocardial infarcfon:the occluded artery trial(OAT)[J].N Engl J Med, 2006; 355(23):1056.
